| |
| |
|
| Insider
Information: |
Loy Bertrand |
| Relationship: |
Director |
| City: |
Acton |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
323,083 |
|
|
Indirect Shares
|
499,633 |
|
|
| Direct
Value |
$33,944,686 |
|
|
|
Indirect Value
|
$1,588,833 |
|
|
| Total
Shares |
822,716 |
|
|
| Total
Value |
$35,533,519 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
7
|
0
|
|
Stock
price went up :
|
7
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
7.0
|
0.0
|
| Percentage
Gain/Loss : |
 71.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Entegris Inc |
ENTG |
President & CEO, Direc... |
2024-04-01 |
263,068 |
2021-08-11 |
0 |
Premium* |
|
|
BTU International Inc |
BTUI |
Director |
2016-01-26 |
3,440 |
2016-01-26 |
0 |
Premium* |
|
|
Harvard Bioscience Inc |
HBIO |
Director |
2024-05-21 |
56,575 |
2024-05-21 |
499,633 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
177 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2022-08-19 |
4 |
B |
$3.28 |
$31,514 |
D/D |
9,608 |
350,968 |
2.39 |
% |
|
| BTUI |
BTU International Inc |
Director |
– • – |
2015-01-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(9,701) |
0 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2021-08-09 |
4 |
AS |
$121.01 |
$1,191,175 |
D/D |
(9,806) |
174,100 |
0 |
% |
|
| ENTG |
Entegris Inc |
Exec VP & CAO |
• – – |
2007-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
203,430 |
0 |
- |
|
| ENTG |
Entegris Inc |
Exec VP & CAO |
• – – |
2007-04-26 |
4 |
AS |
$12.00 |
$125,628 |
D/D |
(10,469) |
206,628 |
0 |
- |
|
| ENTG |
Entegris Inc |
Exec VP & CAO |
• – – |
2007-04-26 |
4 |
OE |
$8.35 |
$87,416 |
D/D |
10,469 |
217,097 |
0 |
- |
|
| ENTG |
Entegris Inc |
Exec VP & COO |
• – – |
2011-05-20 |
4/A |
S |
$8.85 |
$92,907 |
D/D |
(10,495) |
268,636 |
0 |
- |
|
| ENTG |
Entegris Inc |
Exec VP & COO |
• – – |
2011-05-20 |
4 |
S |
$8.85 |
$92,907 |
D/D |
(10,495) |
280,213 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2019-11-12 |
4 |
B |
$2.51 |
$26,553 |
D/D |
10,579 |
187,393 |
2.39 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2022-02-11 |
4 |
D |
$124.48 |
$1,326,085 |
D/D |
(10,653) |
214,715 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2019-09-12 |
4 |
B |
$3.07 |
$34,682 |
D/D |
11,297 |
149,971 |
2.39 |
- |
|
| ENTG |
Entegris Inc |
Exec VP & COO |
• – – |
2011-02-22 |
4 |
AS |
$8.77 |
$101,558 |
D/D |
(11,577) |
247,305 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2016-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
11,800 |
26,200 |
0 |
- |
|
| ENTG |
Entegris Inc |
Exec VP & COO |
• – – |
2011-11-08 |
4 |
AS |
$9.20 |
$109,186 |
D/D |
(11,868) |
234,102 |
0 |
- |
|
| ENTG |
Entegris Inc |
Exec VP & CAO |
• – – |
2008-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
12,094 |
205,577 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2019-11-11 |
4 |
B |
$2.59 |
$33,294 |
D/D |
12,855 |
176,814 |
2.39 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2019-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
149,850 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2023-02-17 |
4 |
D |
$85.48 |
$1,207,490 |
D/D |
(14,126) |
238,546 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2015-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
14,400 |
14,400 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2021-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
14,400 |
286,826 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• – – |
2013-02-20 |
4 |
AS |
$9.75 |
$144,688 |
D/D |
(14,838) |
217,682 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
117,750 |
0 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2022-02-18 |
4 |
D |
$130.19 |
$1,958,448 |
D/D |
(15,043) |
199,672 |
0 |
- |
|
| HBIO |
Harvard Bioscience Inc |
Director |
– • – |
2019-09-11 |
4 |
B |
$3.01 |
$46,926 |
D/D |
15,590 |
138,674 |
2.39 |
- |
|
| ENTG |
Entegris Inc |
President & CEO |
• • – |
2024-02-16 |
4 |
D |
$136.81 |
$2,155,578 |
D/D |
(15,756) |
213,433 |
0 |
- |
|
177 Records found
|
|
Page 3 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
